Business Description
Y-Biologics Inc
ISIN : KR7338840002
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 7.23 | |||||
Equity-to-Asset | 0.77 | |||||
Debt-to-Equity | 0.12 | |||||
Debt-to-EBITDA | -0.15 | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | 4.77 | |||||
WACC vs ROIC |
Growth Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 33.4 | |||||
3-Year EBITDA Growth Rate | -8.3 | |||||
3-Year EPS without NRI Growth Rate | -8.2 | |||||
3-Year FCF Growth Rate | 17.4 | |||||
3-Year Book Growth Rate | 9.5 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 42.8 | |||||
9-Day RSI | 41.17 | |||||
14-Day RSI | 41.63 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.95 | |||||
Quick Ratio | 3.95 | |||||
Cash Ratio | 3.79 | |||||
Days Sales Outstanding | 36.95 | |||||
Days Payable | 0.41 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -9 | |||||
Shareholder Yield % | -8.92 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 71.79 | |||||
Operating Margin % | -246.25 | |||||
Net Margin % | -529.44 | |||||
FCF Margin % | -205.98 | |||||
ROE % | -161.94 | |||||
ROA % | -80.08 | |||||
ROIC % | -44.9 | |||||
ROC (Joel Greenblatt) % | -220.58 | |||||
ROCE % | -151.89 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 31.48 | |||||
PB Ratio | 5.61 | |||||
Price-to-Tangible-Book | 5.67 | |||||
EV-to-EBIT | -5.55 | |||||
EV-to-EBITDA | -5.88 | |||||
EV-to-Revenue | 29.9 | |||||
EV-to-FCF | -14.5 | |||||
Price-to-Net-Current-Asset-Value | 8.83 | |||||
Price-to-Net-Cash | 9.37 | |||||
Earnings Yield (Greenblatt) % | -18 | |||||
FCF Yield % | -5.94 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Y-Biologics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | 3,788.357 | ||
EPS (TTM) (â‚©) | -1588 | ||
Beta | 0 | ||
Volatility % | 0 | ||
14-Day RSI | 41.63 | ||
14-Day ATR (â‚©) | 568.78736 | ||
20-Day SMA (â‚©) | 9721.5 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range (â‚©) | 8480 - 23800 | ||
Shares Outstanding (Mil) | 13.87 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 9999 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Y-Biologics Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Y-Biologics Inc Stock Events
Event | Date | Price(â‚©) | ||
---|---|---|---|---|
No Event Data |
Y-Biologics Inc Frequently Asked Questions
What is Y-Biologics Inc(XKRX:338840)'s stock price today?
When is next earnings date of Y-Biologics Inc(XKRX:338840)?
Does Y-Biologics Inc(XKRX:338840) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |